Effect of Surgical Implantation of Recombinant Human Bone Morphogenetic Protein‐2 in a Bioabsorbable Collagen Sponge or Calcium Phosphate Putty Carrier in Intrabony Periodontal Defects in the Baboon

• Published in: Journal of periodontology (1970) 2002-12, Vol.73 (12), p.1494-1506
• Main Authors: Blumenthal, Neil M., Koh‐Kunst, Grace, Alves, Mario E.A.F., Miranda, Dario, Sorensen, Rachel G., Wozney, John M., Wikesjö, Ulf M.E.
• Format: Article
• Language: English
• Subjects: Alveolar Bone Loss - drug therapy; Analysis of Variance; Animal studies; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins - administration & dosage; bone regeneration; Bone Regeneration - drug effects; Calcium Phosphates; Cementogenesis - drug effects; Collagen; dental cementum/growth and development; Dentistry; Drug Carriers; Drug Implants; Humans; Oral Surgical Procedures - adverse effects; Papio; periodontal attachment; Periodontal Ligament - drug effects; Periodontal Ligament - physiology; periodontal regeneration; Postoperative Care; proteins, bone morphogenetic; Recombinant Proteins - administration & dosage; Regeneration - drug effects; Root Resorption - etiology; Tooth Ankylosis - etiology; Transforming Growth Factor beta; wound healing
• ISSN: 0022-3492; 1943-3670
• DOI: 10.1902/jop.2002.73.12.1494

Background: Recombinant human bone morphogenetic protein‐2 (rhBMP‐2) in a proper carrier has been shown to induce clinically relevant bone formation for several oral/maxillofacial and periodontal indications and to stimulate regeneration of the periodontal attachment. The objective of this study is to evaluate regeneration of alveolar bone, cementum, periodontal ligament, and associated root resorption and ankylosis following surgical implantation of rhBMP‐2 in an absorbable collagen sponge (ACS) or a calcium phosphate putty (αBSM) carrier in 3‐wall intrabony periodontal defects in the baboon. Methods: rhBMP‐2/ACS and rhBMP‐2/αBSM were implanted in surgically produced, maxillary and mandibular, large size, 3‐wall intrabony defects in 4 baboons. Contralateral jaw quadrants were implanted with buffer/ACS, buffer/ αBSM, or served as sham‐operated surgical controls. Treatments were allocated to left and right, maxillary and mandibular, jaw quadrants following a randomization schedule. Four months following implantation, block biopsies of defect sites were obtained, processed, and subjected to histologic and histometric analysis. Results: Defect sites receiving rhBMP‐2/ACS and rhBMP‐2/αBSM demonstrated significantly greater regeneration than controls. No significant differences were observed between defect sites receiving rhBMP‐2/ACS or rhBMP‐2/αBSM regarding epithelial migration and connective tissue attachment and new bone formation. However, rhBMP‐2/ACS supported signifi‐cantly greater new cementum formation. Ankylosis or root resorption were not observed. Conclusions: The results of this study support the use of rhBMP‐2 to enhance periodontal regeneration of intrabony periodontal defects. While this novel technology holds promise, refinement in carrier systems may provide the key to enhancement of the regenerative potential. J Periodontol 2002;73:1494‐1506.